Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem High Dose Chemotherapy and Stem Cell Rescue in High Risk Neuroblastoma
NCT00017368Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Apr 2001
- Primary completion
- Sep 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of thiotepa, cyclophosphamide, carboplatin, etoposide, melphalan in neuroblastoma, sponsored by Children's Oncology Group. Started Apr 2001; status: completed.
02
Drugs
thiotepacyclophosphamidecarboplatinetoposidemelphalan
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00017368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017368.